Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,437 public trials 2,853 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine

NCT00995332

Conditions: Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Haukeland University Hospital and University of Bergen Bergen, Norway

View Trial Details

Completed

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

NCT00083382

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States

View Trial Details

Completed

A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia

NCT01126814

Conditions: Albinism, Amino Acid Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations: Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia

NCT01808326

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukaemia, Lymphoblastic, +3 more
Locations: GSK Investigational Site Aichi, Japan

GSK Investigational Site Fukuoka, Japan

GSK Investigational Site Gunma, Japan

GSK Investigational Site Miyagi, Japan

View Trial Details

Completed

Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy

NCT00990587

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +39 more
Locations: Vancouver General Hospital Vancouver, British Columbia, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Randomized Trial of Iron Supplementation to Prevent Anemia in Very-low-birth-weight Infants

NCT01224236

Conditions: Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases
Locations: Children's Memorial Hermann Hospital Houston, Texas, United States

View Trial Details

Completed

Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM)

NCT01531998

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients

NCT00957385

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: University Health Network, Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients

NCT01195818

Conditions: Albuminuria, Anemia, Anemia, Hemolytic, +18 more
Locations: Centre de la Drépanocytose, Service de Médecine Interne. Hôpital Tenon, 4 Rue de la Chine Paris, France

View Trial Details

Completed

Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

NCT00563290

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +21 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

Ohio State University Medical Center Columbus, Ohio, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions